Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrograde BMAC in Ischemic Heart Failure
NCT03372954Phase 2Completed
- Sponsor
- University Hospital Ostrava
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow cell concentrate in heart failure (HF), sponsored by University Hospital Ostrava. Started Jan 2018; status: completed.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03372954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372954.